Merus (MRUS) Stock Surge Following Abstract Publication News
The publication of an abstract detailing pivotal clinical trial data has significantly boosted the stock price of Merus N.V. (NASDAQ: MRUS) by 36.12% to conclude
The publication of an abstract detailing pivotal clinical trial data has significantly boosted the stock price of Merus N.V. (NASDAQ: MRUS) by 36.12% to conclude
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.